Pills scattered on $100 bills Immunology, oncology and neurology are predicted to drive the most growth in drug spending over the next five years. (Photo: Shutterstock)

Prescription drug use in the U.S. has returned to pre-pandemic levels, and cost trends for medications were flat or declining in 2021, according to a new study. However, out-of-pocket (OOP) costs to consumers continued to increase, the researchers found.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Core and Group Health
Employer-Paid